Baqi Y - Search Results

1

Treatment with A_2A receptor antagonist KW6002 and caffeine intake regulate microglia reactivity and protect retina against transient ischemic damage.

Boia R, Elvas F, Madeira MH, Aires ID, Rodrigues-Neves AC, Tralhão P, Szabó EC, Baqi Y, Müller CE, Tomé ÂR, Cunha RA, Ambrósio AF, Santiago AR. Boia R, et al. Among authors: baqi y. Cell Death Dis. 2017 Oct 5;8(10):e3065. doi: 10.1038/cddis.2017.451. Cell Death Dis. 2017. PMID: 28981089 Free PMC article.

2

Polyoxometalates--a new class of potent ecto-nucleoside triphosphate diphosphohydrolase (NTPDase) inhibitors.

Müller CE, Iqbal J, Baqi Y, Zimmermann H, Röllich A, Stephan H. Müller CE, et al. Among authors: baqi y. Bioorg Med Chem Lett. 2006 Dec 1;16(23):5943-7. doi: 10.1016/j.bmcl.2006.09.003. Epub 2006 Sep 25. Bioorg Med Chem Lett. 2006. PMID: 16997558

3

Rapid and efficient microwave-assisted copper(0)-catalyzed ullmann coupling reaction: general access to anilinoanthraquinone derivatives.

Baqi Y, Müller CE. Baqi Y, et al. Org Lett. 2007 Mar 29;9(7):1271-4. doi: 10.1021/ol070102v. Epub 2007 Mar 10. Org Lett. 2007. PMID: 17348665

4

Catalyst-free microwave-assisted amination of 2-chloro-5-nitrobenzoic acid.

Baqi Y, Müller CE. Baqi Y, et al. J Org Chem. 2007 Jul 20;72(15):5908-11. doi: 10.1021/jo070731i. Epub 2007 Jun 22. J Org Chem. 2007. PMID: 17585825

5

Structure-activity relationships of anthraquinone derivatives derived from bromaminic acid as inhibitors of ectonucleoside triphosphate diphosphohydrolases (E-NTPDases).

Baqi Y, Weyler S, Iqbal J, Zimmermann H, Müller CE. Baqi Y, et al. Purinergic Signal. 2009 Mar;5(1):91-106. doi: 10.1007/s11302-008-9103-5. Epub 2008 Jun 5. Purinergic Signal. 2009. PMID: 18528783 Free PMC article.

6

High-affinity, non-nucleotide-derived competitive antagonists of platelet P2Y12 receptors.

Baqi Y, Atzler K, Köse M, Glänzel M, Müller CE. Baqi Y, et al. J Med Chem. 2009 Jun 25;52(12):3784-93. doi: 10.1021/jm9003297. J Med Chem. 2009. PMID: 19463000

7

Interaction of new, very potent non-nucleotide antagonists with Arg256 of the human platelet P2Y12 receptor.

Hoffmann K, Baqi Y, Morena MS, Glänzel M, Müller CE, von Kügelgen I. Hoffmann K, et al. Among authors: baqi y. J Pharmacol Exp Ther. 2009 Nov;331(2):648-55. doi: 10.1124/jpet.109.156687. Epub 2009 Aug 18. J Pharmacol Exp Ther. 2009. PMID: 19690189

8

Development of potent and selective inhibitors of ecto-5'-nucleotidase based on an anthraquinone scaffold.

Baqi Y, Lee SY, Iqbal J, Ripphausen P, Lehr A, Scheiff AB, Zimmermann H, Bajorath J, Müller CE. Baqi Y, et al. J Med Chem. 2010 Mar 11;53(5):2076-86. doi: 10.1021/jm901851t. J Med Chem. 2010. PMID: 20146483

9

Synthesis of alkyl- and aryl-amino-substituted anthraquinone derivatives by microwave-assisted copper(0)-catalyzed Ullmann coupling reactions.

Baqi Y, Müller CE. Baqi Y, et al. Nat Protoc. 2010 May;5(5):945-53. doi: 10.1038/nprot.2010.63. Epub 2010 Apr 29. Nat Protoc. 2010. PMID: 20431540

10

Discovery of potent competitive antagonists and positive modulators of the P2X2 receptor.

Baqi Y, Hausmann R, Rosefort C, Rettinger J, Schmalzing G, Müller CE. Baqi Y, et al. J Med Chem. 2011 Feb 10;54(3):817-30. doi: 10.1021/jm1012193. Epub 2011 Jan 5. J Med Chem. 2011. PMID: 21207957

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

76 results

Search Page

Filters